ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit Press release … ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit LEIDEN, … July 06, 2023
Lilly and ProQR to Expand RNA Editing Collaboration Press release New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology December 22, 2022
ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing Press release … Leading Intellectual Property Estate for ADAR-mediated RNA Editing LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, … November 06, 2023
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform Press release … ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform LEIDEN, Netherlands & CAMBRIDGE, Mass., … December 22, 2022
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 Press release … ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 LEIDEN, Netherlands … May 09, 2023
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event Press release … Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event Initial pipeline … March 29, 2023
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 Press release … Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 Platform demonstrates … January 19, 2024
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 09, 2022
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 14, 2022
ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing Press release … Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing LEIDEN, Netherlands & CAMBRIDGE, Mass., March 14, … March 14, 2023
